1 year return (CAGR)
139.53%
Dianthus Therapeutics Inc. Exchange (NASDAQ, USD)
DNTH
88.55
-2.73 (-2.92%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
90.17%
5 year return (CAGR)
67.55%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
4.96B
Price/Sales
2604.40
Ent value
4.89B
Price/Book
4.23
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-30.92%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 93.75 |
| Daily high | 94.95 |
| Daily low | 90.36 |
| Daily Volume | 726K |
| All-time high | 115.96 |
| 1y analyst estimate | 140.08 |
| Beta | 0.08 |
| EPS (TTM) | -0.53 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| DNTH | S&P500 | |
| Current price drop from All-time high | -23.64% | -0.84% |
| Highest price drop | -98.17% | -56.47% |
| Date of highest drop | 29 Dec 2022 | 9 Mar 2009 |
| Avg drop from high | -45.67% | -10.68% |
| Avg time to new high | 36 days | 12 days |
| Max time to new high | 1223 days | 1805 days |
News
